Faecal microbiota transplant for recurrent or refractory Clostridioides difficile infection - Medtech innovation briefing [MIB247]

This briefing describes faecal microbiota transplant (FMT), used to treat recurrent or refractory C.difficile infection. A summary of the main relevant evidence is presented along with a key uncertainty in the evidence, the technology’s potential place in therapy and its cost.

Source:

National Institute for Health and Care Excellence

Resource links:

NICE Interventional Procedures guidance: Faecal microbiota transplant for recurrent Clostridium difficile infection